Chlorhexidine Acetate: what the FDA reviewed for dog products

1 Freedom of Information summary from the FDA Center for Veterinary Medicine for products containing Chlorhexidine Acetate, as typed records: every value below is followed by the verbatim passage it was taken from. Species as stated by each summary: Dogs, cats and horses.

Products

Privasan™ Antiseptic Ointment NADA 200-301, Original approval, November 06, 2001; sponsor First Priority, Inc.; species: Dogs, cats and horses; foi_id 1051; FDA PDF

Indication

Topical antiseptic ointment for surface wounds on dogs, cats and horses.

Dose regimen

1 % chlorhexidine acetate ointment (no quantitative dose stated), Topical, Not stated in summary

Amount of Active Ingredients: 1 % chlorhexidine acetate in a hydrophilic ointment Route of Administration: Topical

Extraction notes: Generic ANADA (First Priority, Inc.), OTC. No studies: 'Based upon the formulation characteristics of the generic product, First Priority, Inc. was granted a waiver on June 17, 1999, from conducting an in vivo bioequivalence study for Privasan Antiseptic Ointment.' Pioneer: Nolvasan Antiseptic Ointment, NADA 9-782 (Fort Dodge). The summary gives no dosing frequency or duration; dose_regimen records only strength and route.

Reproduce: foi_structured_search(query="Chlorhexidine Acetate") and foi_summary_get(foi_id=...) in dog-geroscience-mcp; dataset foi-summaries-dog (config structured).